IOBT Historical Financial Ratios
| IOBT Stock | USD 0.96 0.01 1.05% |
IO Biotech is lately reporting on over 89 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.58 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate IO Biotech financial condition quickly.
IOBT |
About IOBT Financial Ratios Analysis
IO BiotechFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate IO Biotech investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on IOBT financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across IO Biotech history.
IO Biotech Financial Ratios Chart
Add Fundamental
Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Income Quality
An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.Most ratios from IO Biotech's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into IO Biotech current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IO Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy IOBT Stock please use our How to Invest in IO Biotech guide.At this time, IO Biotech's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.04 in 2025, whereas Operating Cash Flow Per Share is likely to drop (1.99) in 2025.
IO Biotech fundamentals Correlations
Click cells to compare fundamentals
IO Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
IO Biotech fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | (12.77) | 0.87 | 0.48 | 0.61 | 0.55 | 0.58 | |
| Book Value Per Share | (1.23) | 7.35 | 4.82 | 3.06 | 2.75 | 2.11 | |
| Free Cash Flow Yield | (0.0221) | (0.22) | (0.91) | (0.88) | (1.01) | (0.96) | |
| Operating Cash Flow Per Share | (0.35) | (1.41) | (2.07) | (1.65) | (1.89) | (1.99) | |
| Pb Ratio | (12.77) | 0.87 | 0.48 | 0.61 | 0.55 | 0.58 | |
| Free Cash Flow Per Share | (0.35) | (1.42) | (2.1) | (1.66) | (1.9) | (2.0) | |
| Roic | (3.91) | (0.19) | (0.51) | (0.68) | (0.61) | (0.64) | |
| Net Income Per Share | (0.42) | (2.36) | (2.48) | (1.98) | (2.27) | (2.39) | |
| Cash Per Share | 0.12 | 7.34 | 4.95 | 3.29 | 2.96 | 2.55 | |
| Pocfratio | (45.3) | (4.54) | (1.11) | (1.14) | (1.03) | (1.08) | |
| Pfcf Ratio | (45.3) | (4.52) | (1.1) | (1.14) | (1.02) | (1.07) | |
| Roe | 0.34 | (0.32) | (0.51) | (0.65) | (0.74) | (0.71) | |
| Ev To Operating Cash Flow | (44.95) | 0.67 | 1.23 | 0.82 | 0.74 | 0.78 | |
| Pe Ratio | (37.37) | (2.72) | (0.93) | (0.95) | (0.86) | (0.9) | |
| Return On Tangible Assets | (2.13) | (0.31) | (0.47) | (0.57) | (0.51) | (0.54) | |
| Ev To Free Cash Flow | (44.95) | 0.66 | 1.22 | 0.82 | 0.73 | 0.77 | |
| Earnings Yield | (0.0268) | (0.37) | (1.08) | (1.05) | (1.21) | (1.15) | |
| Current Ratio | 1.85 | 21.52 | 13.88 | 9.37 | 8.43 | 7.6 | |
| Tangible Book Value Per Share | (1.23) | 7.35 | 4.82 | 3.06 | 2.75 | 2.11 | |
| Shareholders Equity Per Share | (1.23) | 7.35 | 4.82 | 3.06 | 2.75 | 2.11 | |
| Graham Net Net | (1.26) | 7.0 | 4.51 | 2.91 | 2.61 | 1.97 | |
| Price Earnings Ratio | (37.37) | (2.72) | (0.93) | (0.95) | (0.86) | (0.9) | |
| Price Book Value Ratio | (12.77) | 0.87 | 0.48 | 0.61 | 0.55 | 0.58 | |
| Price To Operating Cash Flows Ratio | (45.3) | (4.54) | (1.11) | (1.14) | (1.03) | (1.08) | |
| Price To Free Cash Flows Ratio | (45.3) | (4.52) | (1.1) | (1.14) | (1.02) | (1.07) | |
| Ebt Per Ebit | 1.19 | 1.64 | 0.98 | 0.93 | 1.07 | 1.29 | |
| Effective Tax Rate | (0.002159) | (0.001003) | (0.0181) | (0.009996) | (0.0115) | (0.0121) | |
| Company Equity Multiplier | (0.16) | 1.05 | 1.09 | 1.13 | 1.02 | 1.07 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.